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Background: In contemporary practice, the proportion of elderly individuals in the population is growing and the need for percutaneous 
transvenous lead extraction in elderly patients has been increasingly required. The elderly have more risk factors than younger patients needing lead 
extraction. However, the safety of lead extraction for elderly patients remains unclear.
Methods: Between 2005 and 2011, we collected data of 144 consecutive patients who underwent percutaneous transvenous lead extraction 
and compared incidence of major adverse events (MAE; death, myocardial infarction, stroke, cardiac tamponade, PE, blood transfusion or 
pneumohemothorax ) between patients <75 years and patients ≥75 years old. The primary endpoint of this study was incidence of major adverse 
events (MAE; death, myocardial infarction, stroke, cardiac tamponade, PE, blood transfusion or pneumohemothorax ) after procedure. The secondary 
endpoint was hospitalization period.
Results: There were 61 patients (42.3%) with age ≥75 years and 83 patients (57.7%) with age <75 years. The most common indication for lead 
extraction in elderly patients was infection (88.5%). All patients underwent successful transvenous removal of endocardial leads. Three of 61 patients 
(4.9%) had evidence of MAE in elderly patients. No significant difference of MAE was found in the elderly group (4.9 vs. 6.5%, P = 0.921). There was 
no difference in hospitalization periods between those age ≥75 years and age <75 years (41.0±30.6 days vs 32.3±26.3 days, P =0.096).
Conclusions: In elderly patients, percutaneous transvenous lead extraction could be performed safely without prolonged hospital stay.
